Opentrons Secures $40M for Robotics and AI Expansion
Opentrons Labworks has raised $40 million from a Series E financing round led by healthcare…
Newswire
Parse and Nomic Create 100 Million-Cell Dataset
Parse Biosciences, a QIAGEN company, and Nomic Bio have partnered to generate Cascade, a 100…
Building Resilience into Biologics Supply Chains
For biologics sponsors, true CDMO capacity depends on more than open slots—it requires the right…
IDWeek 2026: Phase III Trial Analysis of Ensitrelvir PEP
At IDWeek 2026, Akimasa Fukushi from Shionogi presented a subpopulation analysis of the Phase III…
David Liu Highlights Gene Editing Progress at ESGCT 2026
David Liu, PhD, emphasized the significant advancements in therapeutic genome editing during his plenary session…
Prediction Markets Raise Insider Trading Concerns for Biotechs
Legal experts warn that betting on pharmaceutical outcomes through platforms such as Kalshi and Polymarket…
Merck and Moderna Discuss mRNA Cancer Vaccine Advances
On this week’s episode of “The Readout LOUD,” STAT’s biotech podcast, the latest cancer data…
Yuyu Pharma Explores Veterinary Medicine for Drug Development
Yuyu Pharma is exploring opportunities in veterinary medicine to expand its pharmaceutical business and identify…
BioMarin Licenses Investigational Fabry Disease Therapy
BioMarin Pharmaceutical has secured exclusive worldwide rights, excluding South Korea, to an investigational enzyme replacement…
MilliporeSigma Opens $350 Million Bioprocessing Facility in South Korea
MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has opened…